Heart failure hospitalisation or cardiovascular death with empagliflozin in patients with type 2 diabetes and high cardiovascular risk: analysis over time

P van de Borne, Joseph Selvanayagam, J George, J. Lee, M Mattheus, H J Woerle, D Fitchett

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S534-S535
Number of pages2
Publication statusPublished - 2016

Cite this